3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
24
Burkitt Lymphoma
20
Leukemia, Biphenotypic, Acute
12
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
6
Leukemia, Myeloid, Acute
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Osteosarcoma
4
Leukemia
4
Neoplasm Metastasis
3
Myelodysplastic Syndromes
3
Down Syndrome
3
Rhabdoid Tumor
2
Recurrence
2
Myeloproliferative Disorders
2
Lymphoma, Mantle-Cell
2
Lymphoma
2
Leukemia, Myeloid, Accelerated Phase
2
Head and Neck Neoplasms
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Blast Crisis
2
Urothelial Carcinoma of the Bladder
1
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Shwachman-Diamond Syndrome
1
Sarcoma, Ewing
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Multiple Myeloma
1
Interventions
pembrolizumab
2
durvalumab
2
Tretinoin
2
Paclitaxel
2
Oxaliplatin
2
Irinotecan
2
Chemoradiotherapy
2
Carboplatin
2
Capecitabine
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
tislelizumab
1
tegafur-gimeracil-oteracil
1
talazoparib
1
sarilumab
1
relugolix
1
pexidartinib
1
pertuzumab
1
patritumab
1
olaparib
1
niraparib
1
neratinib
1
ganitumab
1
enzalutamide
1
dostarlimab
1
cemiplimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
Methotrexate
×
90 days
×
Clear all
No trials found.